Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial
収録刊行物
-
- The Lancet Oncology
-
The Lancet Oncology 15 (12), 1369-1378, 2014-11
Elsevier BV